Search research articles
Contact Us
Filters
Showing results (1-10 of 175) with videos related to
Page
of 18
Sort By:
Cancer Treatment and Research
|
June 26, 2004
Targeted therapy: ready for prime time?
Caroline Seynaeve, Jaap Verweij
The Lancet. Oncology
|
March 3, 2006
Can bilateral prophylactic salpingo-oophorectomy reduce cancer mortality in carriers of a BRCA1 or BRCA2 mutation?
Cecile T M Brekelmans, Caroline Seynaeve
Current Opinion in Oncology
|
September 1, 2007
Gynaecological sarcomas
Stefan Sleijfer, Caroline Seynaeve, Jaap Verweij
Lancet (London, England)
|
May 17, 2005
Tailoring breast cancer therapy to genetic status
Caroline Seynaeve, Cecile T M Brekelmans
The Oncologist
|
November 30, 2005
Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care
Stefan Sleijfer, Caroline Seynaeve, Jaap Verweij
Advances in Experimental Medicine and Biology
|
July 3, 2008
GIST as the model of paradigm shift towards targeted therapy of solid tumors: update and perspective on trial design
Jaap Verweij, Caroline Seynaeve, Stefan Sleijfer
Clinical Colorectal Cancer
|
November 15, 2006
Practical aspects of managing gastrointestinal stromal tumors
Stefan Sleijfer, Caroline Seynaeve, Erik Wiemer, et al.
The Oncologist
|
July 3, 2007
Improved insight into resistance mechanisms to imatinib in gastrointestinal stromal tumors: a basis for novel approaches and individualization of treatment
Stefan Sleijfer, Erik Wiemer, Caroline Seynaeve, et al.
JAMA
|
December 24, 2010
Association of risk-reducing surgery with cancer risks and mortality in BRCA mutation carriers
Bernadette A M Heemskerk-Gerritsen, Mieke Kriege, Caroline Seynaeve
Pharmacy World & Science : PWS
|
November 6, 2010
Severe akathisia as a side effect of metoclopramide
Arthur R Van Gool, Jeanette K Doorduijn, Caroline Seynaeve
Page
of 18
Search research articles
Search
Showing results (1-10 of 175) with videos related to
Sort By:
Page
of 18
Cancer Treatment and Research
|
June 26, 2004
Targeted therapy: ready for prime time?
Caroline Seynaeve, Jaap Verweij
The Lancet. Oncology
|
March 3, 2006
Can bilateral prophylactic salpingo-oophorectomy reduce cancer mortality in carriers of a BRCA1 or BRCA2 mutation?
Cecile T M Brekelmans, Caroline Seynaeve
Current Opinion in Oncology
|
September 1, 2007
Gynaecological sarcomas
Stefan Sleijfer, Caroline Seynaeve, Jaap Verweij
Lancet (London, England)
|
May 17, 2005
Tailoring breast cancer therapy to genetic status
Caroline Seynaeve, Cecile T M Brekelmans
The Oncologist
|
November 30, 2005
Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care
Stefan Sleijfer, Caroline Seynaeve, Jaap Verweij
Advances in Experimental Medicine and Biology
|
July 3, 2008
GIST as the model of paradigm shift towards targeted therapy of solid tumors: update and perspective on trial design
Jaap Verweij, Caroline Seynaeve, Stefan Sleijfer
Clinical Colorectal Cancer
|
November 15, 2006
Practical aspects of managing gastrointestinal stromal tumors
Stefan Sleijfer, Caroline Seynaeve, Erik Wiemer, et al.
The Oncologist
|
July 3, 2007
Improved insight into resistance mechanisms to imatinib in gastrointestinal stromal tumors: a basis for novel approaches and individualization of treatment
Stefan Sleijfer, Erik Wiemer, Caroline Seynaeve, et al.
JAMA
|
December 24, 2010
Association of risk-reducing surgery with cancer risks and mortality in BRCA mutation carriers
Bernadette A M Heemskerk-Gerritsen, Mieke Kriege, Caroline Seynaeve
Pharmacy World & Science : PWS
|
November 6, 2010
Severe akathisia as a side effect of metoclopramide
Arthur R Van Gool, Jeanette K Doorduijn, Caroline Seynaeve
Page
of 18